Molecular Diagnostics

In Other News

• Blood-Based Assay Detects HER2 Mutations to Guide NSCLC Treatment

• Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer

• New Library Normalization and Amplification Tools Support Oncology Sequencing

• Statistical Method Improves Detection of Low-Level Cancer DNA in Blood Samples

• AI Tool Improves Accuracy of Cancer Liquid Biopsy for Therapy Selection

• Study Highlights Inherited Breast Cancer Risk Genes in Young Black Women

• Targeted RNA Test Enhances Genetic Diagnosis in Exome Sequencing

• Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer

• Blood Test Predicts Immunotherapy Response in Head and Neck Cancer

• New PCR Assay Supports Bundibugyo Ebola Outbreak Surveillance

• AI-Enabled Spatial Multi-Omics Maps Colorectal Tumor Architecture

• Plasma Protein Signature Predicts Lung Cancer Risk Up to Five Years Ahead

• Circulating Tumor DNA Testing Guides Chemotherapy, Reduces Relapse in Colon Cancer

• Researchers Uncover Distinct Chromosome Signature in Aggresive ALT Cancers

• Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer

• Simple Cytogenetic Method Could Improve Classification of ALL Subtypes

• Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

• Tumor Mutation Marker Helps Refine Lung Cancer Prognosis and Guide Therapy Selection

• Multi-Cancer Test Boosts Detection When Added to Standard Screening

• Blood-Based MRD Monitoring Supports Relapse Prevention in Leukemia

• Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

• Blood Protein Markers Flag Multiple Sclerosis Risk Years Before Diagnosis

• MCED Blood Test Reduces Stage IV Cancer Diagnoses in NHS Trial